The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis

Background: Colonization by Aspergillus fumigatus in patients with cystic fibrosis (CF) can cause A fumigatus sensitization and/or allergic bronchopulmonary aspergillosis (ABPA), which affects pulmonary function and clinical outcomes. Recent studies show that specific allergens upregulate the surfac...

Full description

Saved in:
Bibliographic Details
Main Authors: Mirković, Bojana, Lavelle, Gillian M., Azim, Ahmed Abdul, Helma, Kristine, Gargoum, Fatma S., Molloy, Kevin, Gernez, Yael, Dunne, Katie, Renwick, Julie, Murphy, Philip, Moss, Richard B., Greene, Catherine M., Gunaratnam, Cedric, Chotirmall, Sanjay Haresh, McElvaney, Noel G.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2016
Subjects:
Online Access:https://hdl.handle.net/10356/81769
http://hdl.handle.net/10220/39941
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-81769
record_format dspace
spelling sg-ntu-dr.10356-817692020-11-01T05:19:41Z The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis Mirković, Bojana Lavelle, Gillian M. Azim, Ahmed Abdul Helma, Kristine Gargoum, Fatma S. Molloy, Kevin Gernez, Yael Dunne, Katie Renwick, Julie Murphy, Philip Moss, Richard B. Greene, Catherine M. Gunaratnam, Cedric Chotirmall, Sanjay Haresh McElvaney, Noel G. Lee Kong Chian School of Medicine (LKCMedicine) Basophil activation test CD203c Cystic fibrosis Aspergillus fumigatus Body mass index Flow cytometry FEV1 Itraconazole, sensitization Allergic bronchopulmonary aspergillosis Background: Colonization by Aspergillus fumigatus in patients with cystic fibrosis (CF) can cause A fumigatus sensitization and/or allergic bronchopulmonary aspergillosis (ABPA), which affects pulmonary function and clinical outcomes. Recent studies show that specific allergens upregulate the surface-expressed basophil marker CD203c in sensitized subjects, a response that can be readily measured by using flow cytometry. Objective: We sought to identify A fumigatus sensitization in patients with CF by using the basophil activation test (BAT). Methods: Patients with CF attending Beaumont Hospital were screened for study inclusion. BAT was used to identify A fumigatus sensitization. Serologic (total and A fumigatus–specific IgE), pulmonary function, and body mass index measurements were performed. Results: The BAT discriminates A fumigatus–sensitized from nonsensitized patients with CF. Persistent isolation of A fumigatus in sputum is a significant risk factor for A fumigatus sensitization. Levels of the A fumigatus–stimulated basophil activation marker CD203c inversely correlated with pulmonary function and body mass index in A fumigatus–sensitized but not nonsensitized patients with CF. Total and A fumigatus–specific IgE, but not IgG, levels are increased in A fumigatus–sensitized patients with CF and ABPA when compared with those in A fumigatus–sensitized and nonsensitized patients with CF without ABPA. Itraconazole treatment did not affect A fumigatus sensitization. Conclusion: Combining the BAT with routine serologic testing allows classification of patients with CF into 3 groups: nonsensitized, A fumigatus–sensitized, and ABPA. Accurate and prompt identification of A fumigatus–associated clinical status might allow early and targeted therapeutic intervention, potentially improving clinical outcomes. Accepted version 2016-02-03T07:50:19Z 2019-12-06T14:40:16Z 2016-02-03T07:50:19Z 2019-12-06T14:40:16Z 2015 Journal Article Mirković, B., Lavelle, G. M., Azim, A. A., Helma, K., Gargoum, F. S., Molloy, K., et al. (2015). The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis. Journal of Allergy and Clinical Immunology, 137(2), 436-443. 0091-6749 https://hdl.handle.net/10356/81769 http://hdl.handle.net/10220/39941 10.1016/j.jaci.2015.07.045 en Journal of Allergy and Clinical Immunology © 2015 American Academy of Allergy, Asthma & Immunology. This is the author created version of a work that has been peer reviewed and accepted for publication in Journal of Allergy and Clinical Immunology, published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document.  The published version is available at: [http://dx.doi.org/10.1016/j.jaci.2015.07.045]. 36 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Basophil activation test
CD203c
Cystic fibrosis
Aspergillus fumigatus
Body mass index
Flow cytometry
FEV1
Itraconazole, sensitization
Allergic bronchopulmonary aspergillosis
spellingShingle Basophil activation test
CD203c
Cystic fibrosis
Aspergillus fumigatus
Body mass index
Flow cytometry
FEV1
Itraconazole, sensitization
Allergic bronchopulmonary aspergillosis
Mirković, Bojana
Lavelle, Gillian M.
Azim, Ahmed Abdul
Helma, Kristine
Gargoum, Fatma S.
Molloy, Kevin
Gernez, Yael
Dunne, Katie
Renwick, Julie
Murphy, Philip
Moss, Richard B.
Greene, Catherine M.
Gunaratnam, Cedric
Chotirmall, Sanjay Haresh
McElvaney, Noel G.
The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
description Background: Colonization by Aspergillus fumigatus in patients with cystic fibrosis (CF) can cause A fumigatus sensitization and/or allergic bronchopulmonary aspergillosis (ABPA), which affects pulmonary function and clinical outcomes. Recent studies show that specific allergens upregulate the surface-expressed basophil marker CD203c in sensitized subjects, a response that can be readily measured by using flow cytometry. Objective: We sought to identify A fumigatus sensitization in patients with CF by using the basophil activation test (BAT). Methods: Patients with CF attending Beaumont Hospital were screened for study inclusion. BAT was used to identify A fumigatus sensitization. Serologic (total and A fumigatus–specific IgE), pulmonary function, and body mass index measurements were performed. Results: The BAT discriminates A fumigatus–sensitized from nonsensitized patients with CF. Persistent isolation of A fumigatus in sputum is a significant risk factor for A fumigatus sensitization. Levels of the A fumigatus–stimulated basophil activation marker CD203c inversely correlated with pulmonary function and body mass index in A fumigatus–sensitized but not nonsensitized patients with CF. Total and A fumigatus–specific IgE, but not IgG, levels are increased in A fumigatus–sensitized patients with CF and ABPA when compared with those in A fumigatus–sensitized and nonsensitized patients with CF without ABPA. Itraconazole treatment did not affect A fumigatus sensitization. Conclusion: Combining the BAT with routine serologic testing allows classification of patients with CF into 3 groups: nonsensitized, A fumigatus–sensitized, and ABPA. Accurate and prompt identification of A fumigatus–associated clinical status might allow early and targeted therapeutic intervention, potentially improving clinical outcomes.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Mirković, Bojana
Lavelle, Gillian M.
Azim, Ahmed Abdul
Helma, Kristine
Gargoum, Fatma S.
Molloy, Kevin
Gernez, Yael
Dunne, Katie
Renwick, Julie
Murphy, Philip
Moss, Richard B.
Greene, Catherine M.
Gunaratnam, Cedric
Chotirmall, Sanjay Haresh
McElvaney, Noel G.
format Article
author Mirković, Bojana
Lavelle, Gillian M.
Azim, Ahmed Abdul
Helma, Kristine
Gargoum, Fatma S.
Molloy, Kevin
Gernez, Yael
Dunne, Katie
Renwick, Julie
Murphy, Philip
Moss, Richard B.
Greene, Catherine M.
Gunaratnam, Cedric
Chotirmall, Sanjay Haresh
McElvaney, Noel G.
author_sort Mirković, Bojana
title The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
title_short The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
title_full The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
title_fullStr The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
title_full_unstemmed The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis
title_sort basophil surface marker cd203c identifies aspergillus sensitization in 2 cystic fibrosis
publishDate 2016
url https://hdl.handle.net/10356/81769
http://hdl.handle.net/10220/39941
_version_ 1683493655435804672